HUP0200345A2 - Novel nucleic acid transferring agents, compositions containing them and uses - Google Patents

Novel nucleic acid transferring agents, compositions containing them and uses

Info

Publication number
HUP0200345A2
HUP0200345A2 HU0200345A HUP0200345A HUP0200345A2 HU P0200345 A2 HUP0200345 A2 HU P0200345A2 HU 0200345 A HU0200345 A HU 0200345A HU P0200345 A HUP0200345 A HU P0200345A HU P0200345 A2 HUP0200345 A2 HU P0200345A2
Authority
HU
Hungary
Prior art keywords
nucleic acid
compositions containing
novel nucleic
transferring agents
acid transferring
Prior art date
Application number
HU0200345A
Other languages
Hungarian (hu)
Inventor
Jean Herscovici
Hans Hofland
Christophe Jacopin
Daniel Scherman
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9815309A external-priority patent/FR2786700B1/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0200345A2 publication Critical patent/HUP0200345A2/en
Publication of HUP0200345A3 publication Critical patent/HUP0200345A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány tárgyát új transzferáló ágensek, azokat tartalmazókészítmények, és a nukleinsavaknak sejtekbe történő in vitro, in vivoés ex vivo transzferálására való alkalmazásuk képezik. Pontosabban, atalálmány olyan új nukleinsav-transzferáló ágensekre vonatkozik,amelyek egy - egyrészt egy polikationhoz, másrészt legalább egyhidrofil szubsztituenshez kémiailag kapcsolódó - hidrofób kapcsottartalmaznak. ÓThe subject of the invention is new transfer agents, preparations containing them, and their use for in vitro, in vivo and ex vivo transfer of nucleic acids into cells. More specifically, the invention relates to new nucleic acid transfer agents that contain a hydrophobic link chemically linked to a polycation on the one hand and at least one hydrophilic substituent on the other. HE

HU0200345A 1998-12-03 1999-12-02 Novel nucleic acid transferring agents, compositions containing them and uses HUP0200345A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815309A FR2786700B1 (en) 1998-12-03 1998-12-03 NOVEL NUCLEIC ACID TRANSFERS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF
US11718499P 1999-01-26 1999-01-26

Publications (2)

Publication Number Publication Date
HUP0200345A2 true HUP0200345A2 (en) 2002-05-29
HUP0200345A3 HUP0200345A3 (en) 2003-12-29

Family

ID=26234691

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200345A HUP0200345A3 (en) 1998-12-03 1999-12-02 Novel nucleic acid transferring agents, compositions containing them and uses

Country Status (13)

Country Link
EP (1) EP1137793A2 (en)
JP (1) JP2002531468A (en)
KR (1) KR20010101116A (en)
CN (1) CN1348498A (en)
AU (1) AU772033B2 (en)
BR (1) BR9915897A (en)
CA (1) CA2353576A1 (en)
CZ (1) CZ20011909A3 (en)
HU (1) HUP0200345A3 (en)
IL (1) IL142704A0 (en)
NO (1) NO20012684L (en)
PL (1) PL348513A1 (en)
WO (1) WO2000032803A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805271B1 (en) * 2000-02-18 2002-04-26 Aventis Pharma Sa PROCESS FOR THE PREPARATION OF FUNCTIONALIZED POLYALKYLENIMINES, COMPOSITIONS CONTAINING THEM AND USES THEREOF
JP2005080598A (en) * 2003-09-10 2005-03-31 Japan Science & Technology Agency METHOD FOR INTRODUCING PLASMID DNA BY USING beta-1,3-GLUCAN DERIVATIVE
CN103820320B (en) * 2013-06-25 2017-03-15 宁波有成生物医药科技有限公司 Liquid protected by a kind of non-jelly type RNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021036A2 (en) * 1994-12-30 1996-07-11 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
FR2730637B1 (en) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa PHARMACEUTICAL COMPOSITION CONTAINING NUCLEIC ACIDS, AND USES THEREOF
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
WO2000032803A3 (en) 2000-10-12
EP1137793A2 (en) 2001-10-04
NO20012684D0 (en) 2001-05-31
IL142704A0 (en) 2002-03-10
PL348513A1 (en) 2002-06-03
KR20010101116A (en) 2001-11-14
JP2002531468A (en) 2002-09-24
HUP0200345A3 (en) 2003-12-29
AU1564600A (en) 2000-06-19
CN1348498A (en) 2002-05-08
BR9915897A (en) 2001-08-21
NO20012684L (en) 2001-07-30
CZ20011909A3 (en) 2001-09-12
CA2353576A1 (en) 2000-06-08
AU772033B2 (en) 2004-04-08
WO2000032803A2 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
FI962799A0 (en) Nucleic acid preparation, its preparation and use
NO973745D0 (en) Nucleic acid-containing preparation, its preparation and use
NO995808L (en) Compounds, their preparation and use for the transfer of nucleic acids into cells
BR0112094A (en) Confectionery containing active ingredients
EE9700133A (en) Method for modifying the characteristics of mammalian reproductive cells, composition used, method of preparation and use
HUP0200345A2 (en) Novel nucleic acid transferring agents, compositions containing them and uses
IL137247A0 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
HUP0202744A2 (en) Oral controlled release formulations containing rivastigmine
HUP0003418A2 (en) Synthetic divalent slex containing polylactosamines and methods for use
HUP0102413A1 (en) Nucleic acid transfer vectors, compositions containing same and uses
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
HRP20020071B1 (en) Pharmaceutical composition and preparation thereof
HUP0102455A2 (en) Novel nucleic acid transfer agents, compositions containing same and uses
IT1250658B (en) PHARMACEUTICAL COMPOSITIONS USABLE IN GASTROENTEROLOGY
MX9801920A (en) Pharmaceutical composition useful for nucleic acid transfection, and use thereof.
ES2078159B1 (en) CANDIDA ALBICANS THERMAL SHOCK MANOPROTEIC ANTIGENS AND THEIR USE IN THE DIAGNOSIS OF CANDIDIASIS.